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Thrombolytic therapy of acute myocardial infarctmn has 
become on established procedure for repxfusion of oc- 
cluded coronary arteries. resulting in reduction of infarct 
size and preservation of left ventricular function (I). A 
reduced incidence of death from acute myocardial infarction 
has now been demonstrated after thrombolytic therapy with 
strcptokinase, acylated plasminaggen-slreptokinase ctivator 
complex (APSAC. aoisireplaxe) and recombinant issue-type 
plasminogen activator @t-PA. alteptase) (2-5). Tbrombolytic 
therapy with the most potent agent, r&PA. still orrly repa- 
fuses approximately 70% ofoccluded coronary arteries (6). a 
threshold that is not owrcon~e by either combined infusion 
of therapeutic doses of n-PA and urokinase (7) or intracor- 
onary administration of streptokinase (6). 
One cause of resistance of coronary occlusive thrombus 
to dissolution by thrombolytic agents may be a predom- 
inanceofplatelet-rich thrombus. Such ditTerential sensitivity 
to dissolution with rt-PA of platelet-rich thrombus relatwe 10 
erythrocyte-rich thrombus was demonwaled in a model of 
femoral artery thrombosis in the rabbit (9). Furthermore. 
postmortem examination of serial sections of coronary 
thromhus from patients who died with acute myoxrdial 
infarction has consistently revealed areas of platelet-rich 
thmmbns contiguous to the site of plaque rupture lI01. 
However. it is unknown how often this platelet-rich material 
occupies the entire lumen in the region of plaque rupture. In 
a dog model of coronary anery thromholysrs wrh supenm- 
pwed endothelial cell damage and stenosis, ‘we previously 
d~umented(ll)theconsistentoccu~nce afreocclusion hy coronae 
material highly enriched in blood platelets. an observaban 
tbai also supports the wcurrence and potential role of 
platelet-rich thrombus in coronary occlusion. 
In the present study. we developed a dog model of 
platelet-rich coronary artery thrombus using eversion of a 
circumflex coronary artery sego~eot. In a mbho femoral Fiyre 1. Schematic reprermWion of the canine erperimenul 
artery evasion segment model, we have previously shown prepnralion ofa plsrelet-nch t mmbus in the evened len crcnmflex 
that exposure of the adventitial surface to Rowing blood coronary xtery ie@,cn,. With P distal co”strictoi ~tiucmg high 
results io platelet adhesion and aggregation in the everted 
yade stenosis and a pwximal Doppler Row probe. For details. see 
,ex,. 
segment, leading to occlusion with material highly enriched 
in platelets. The effect of single or combined bolns injections 
of It-PA and F(ab’)Z tiagments of the antiplatelet GPllhlIlla 
antibody 7E3 (12) was investigated to confirm the resistance 
of platelet-rich tbmmhus to thrombolytic agents and to 
initiate the investigation of strategies to overcome this 
resistance. This present model, in which the primary occlu- 
sive thrombns is p!atelet rich, ditTers fundamentally from our 
previous dog model (II), in which the occlusive thmmhus 
w8.s a whole blood clot. In that model, it was not posstble to 
investigate the sensitivity of preformed platelet-rich throm- 
bus to repeltusion strategies. 
Methods 
tie (Mawachusetts Gas and Electric Supply) placed around 
the comn~ry arte~ distal to the eversion graft and ion- 
stwed to reduce the blood Row to 40 c IO% of the baseline 
value. This constriction corresponds to a >W% reduction in 
luminal diameter as demonstrated by postmortem angiogra- 
phy (III. The left circumEex coronary artery %tis then 
dissected out of the eprardium and a 1 cm segment was
excised Lwtwcen two miemvascular clamps. stripped ofexces 
sive adventitial tissue. everted inside out 2nd reinserted by end 
to end aoastomoois using 8 to I2 intenapted sutores with 7-O 
nvlon IShamoint 1nc.l. The microvasctdar clamo occlndina the 
proximal ad distat ends of the ttanseclcd a&y was ihen 
released. The sutical orocedure wan carried out without an 
Reagents. Single chain rt-PA (G-11044. Activase) was extracorporeal ci&atibn device. 
supplied by Genentech and F(aW fragments of a murine Coronary angiography WE performed by manual injec- 
monoclonal antibody directed against the human platelet tion of Renogsatin-76 through a modified Judkins ‘IF left 
GPWllla receptor (7E3) by Centocor. Amplatz catheter inserted from a carotid artery. 
Everted dreumtkx eonmary ariery segment preparation. After release of the vessel clamps, blood Row was re- 
This dog model is schematically represented in Figure I. stored in 2S of the 27 dogs. This was followed by spontane- 
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were anesthetized with intravenous sodium pcntobarbital. least 30 min in 20 dogs, ocssning within 4.J * 3.5 min as 
intubated and artificially ventilated. A left thoracotomy was demonstrated with t e Row probe (decrease in blood Row to 
performed, and the internal mammary artery was csnnulated co.5 mlimin) and confirmed by angiagraphy. These 20 dogs 
for continuous blood pressure monitoring. tntnmuscular were used in Ihe present study. All st?rdies involving exper- 
pmeainamide (1.5 gi. infravenous lidocaine I75 mg halos imental animals conformed to the “Position ofthe American 
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given. A TlOl ultrasound blood flow meter (Transsonic Infuston protwts (T&k 1). Four trexment gioups of 
Systems, Inc.) was placed wound the left circumflex core five dogs each were studied: control dogs without 7E3- 
nary artery proximal to the site of the eversion graft. A F(ab’l2 or rt-PA (group I). dogs given rt-PA alone as 
stenosis was then produced with a 2 mm wide, plastic wire 0.45 mg’kg body weight bolus injections at 15 min intWWls 
until repafusion occurred or up to a total of four bolus 
injections (groap II), dogs receiving 7E3-F(&‘)Z BS P single 
bolus injection of 0.8 mgikg (group HI) and dogs given a 
combination of 0.8 mglkg of 7E3-F(ab’)Z followwl IO min 
later by a bolus injection of&45 mglkg of r&PA repeated at 
I5 min intervals until rcpetfusion occurred (proup IV). The 
rcperftisiao uutc was taken as the lime from the first injec- 
tion of R-PA or 7E3-F(ab’)Z until rcpcrfusion was docu- 
mented by both the return ofblood Row to 21 mllmin in the 
circumflex ccwnary artery and anaiwraohic confirmation of 
complete lilliog dis& to the everteb &&mt, with clearance 
ofdye within four heartbeats. No additional r&PA was eiven 
to dbgs reaching this end point. even if reocclusion folliwed. 
After rcperfusion had occurred, blood flow was continuously 
monitored for evidence of rcocdusion. with the final ionfir- 
mation by angiography with the use of the same criteria as 
for establishing reperfusion. The rcocclusion time was taken 
as the interval between documented rcpcrfusion and rcoc- 
elusion, which was defined as a decrease in blood Row to 
cl mllmin. Dogs were observed for at least 90 min after the 
first injection of rt-PA or 7E3-F(ab’)Z. 
Pathologk examinrtiin. At the end ofthe experiment, the 
dogs were killed with an overdose of pcntobarbital. The 
proximal circumflex artery was cannulated and perfusion 
fixed with 0.1 M of cacodvlate-buffered 0.25% elutaralde- 
hyde at 80 to 100 mm Hg pr&urc for i5 min. Thihean was 
then fired intact in the same fixative. The everted segment 
with the adjacent 0.5 cm of proximal awry and the distal 
stenosis was removed from the heart and processed for light 
microscopy. Longitudmal sections were cut and stained with 
bcmatoxylin-eosin. 
Bload analyses. Venous blood samples for olalelet and 
plasma assays were collected in 0.01 .& of cit& and 200 
kzdlikrcin inhibitor units (KIU) of aprotininlml (Sigma). 
Platelet-rich plasma was prepared immediaiely and tested 
for adenosine diphospbate (ADP)-u.luced platelet aggrcga. 
lion and measurement of GPllbltIla iaturation by iodinc- 
l25-7E3 binding as previously desrribd (121. Plasma was 
prepared from blood kept &ice until the end of the 
experiment, then centrifuged at room temperature and 
stored at -2WC. Fibrinogen was measured by a coagulrdion 
rate assay (13) that is insensitive to therapeutic conccotm- 
lions of heparin (14); and tissue plasminogen activator (t-PA) 
antigen was measured with a monwloral antibody-bared 
enzyme-linked immunosorbent assay (IS) that daes not 
cross-react with canine t-PA. Venous blood samriles col- 
lected in ethylenediaminetetra-aeetic acid(EDTA) were also 
obtained for measoremcnt of the platelet count. Bleeding 
times were obtained before and 30 min after the first injec- 
tion of R-PA or 7E3-F(W)2 and toward the end of the 
exwbncnt with a spring-loaded blade device (Surgicott 
International. Technidyne Corp.) apphed to a shaved forc- 
leg. 
Stattsttcd matysk. Data are expressed as mean values ? 
SD. The significance of diffcnences between groups was 
determined with Fisher’s exact test or Student’s I test for 
paired or unpmred values. 
Results 
Coronary mIcry rewrluion and rcomlusion (Table I. 
Fig. 2). Baseline c&tRex coronary artery blood flow of I7 
to 25 mllmin was reduced to acumximatelv 40% of baseline 
(between 7 and I I mllmin) b;;xternal &nstriction. After 
clamp release following reinsertion of the evened segment. 
blood Pow was reestablished between 3.3 and 5.5 mUmin 
before occlusiaa occurred. In the control group (group 1. n = 
5). stable circumflex coronary artery occlusion was main- 
tained throughout the observation period in all Ive dogs. In 
group11 (n = 5). bolus injectionsofO.45 mglkgofrt-PA alone 
repeated up to four times at I5 win intervals did not cause 
repcrfusion in four of the five dogs, whereas in the titlh dog 
cyclic reflow was observed after the first bolos injection. In 
group 111 (n = 5). when 0.8 m& of 7E3.F(ab’)Z was 
injected after stable occlusion for M min. reperfusion oc- 
cured in two of the five dogs (after II and 30 min. rcspcc- 
lively) and was followed by stable patency during the 
remainder of the observation period. In the other three dogs. 
occlusion persisted throughout the observation period. in 
group IV (n = 51. whrn 0.8 mgkg of 7E3-F(ab’)Z WPS 
combined with one or two bolus injections of 0.45 mglkg of 
rt-PA. stable repcrfusion without rcoeclusion was abawd 
FIgwe 2. Schemauc rcpre~cnr:~,~on of 
left circumllex cnronary artery perfwon 
slritm in 20 dogs. Group I = conlrol 
group: Group II = group recewing 0 45 
mglkg recombinnnr tirswrype planw 
nogen acrivalor ,n-?A, Mu\ in,ccllo”\. 
Sroup 111 = group receiving 0.8 @kg 
lE3_Flab’l2 bolur injecliuns GrOUQ IV 
= group with combined r&PA ;md ES 
F(ab’)Z b&r in&dons: T = rr-PA ur- 
jection: V = 7E3-FCah’j2 m,ccuon: 
h~tehd hat = ccclusion: open bnr = 
reperfurion 
in all five dogs within 9 2 7 min. After reperfuian. blood 
Row returned IO a level comparable wh rhar before occlu- 
sion. 
The statistical significance of the difference in frequewy 
of repelfusion in groop IV versus groups 1. II and III is p < 
0.01, p < 0.05 and p < 0.17. respectively. Additional details 
on the perfusion states of the cmmary artery in these 
experimental animals are ropresec\ed in Figure 1. The heart 
rate and blood pressure drd not change significantly from 
baseline values when measured I h after the r:kase of *he 
vessel clamps (data not shown). 
liemc&&s snaly~ (Tables 2 and 3). Template bleeding 
times (Table 2) measured before injection of rt-?A or 7E3- 
F(ab’)Z ranKed between 2 and 7 min and remained un- 
changed Ihmughouc the observation period in the control 
group (group I) 8s well as in the group given SPA bolus 
injections (group II). I~ection ofo.8 mg of7E3-F(ah’)2 alone 
(group 111) or in cambinatian with r&PA (group IV) rewllcd 
in a prolongation of the bleeding time to >30 min in ali dogs 
studied (p < O.Wl). Injection of the antibody was associated 
with a decrease in the platelet count by approximately IS% 
(p < 0.05). with a s&ration of the plateiet GPllblllla 
receptors of belween 80% and 90% and compkle iohibition 
of ADP-induced platelet aggregation. The rt-PA bolus injec- 
tions caused an increase in the plasma rt-PA level to approx- 
innlrly IO p#ml measured I min after the b&s inJeciion. 
nhlch decreaed to between I and j pg withm I5 min and to 
0.05 Io 0 .?R &rni toward Ihe end of the observarion period 
(Table 31. Fibrinogen levels decreased by an average of 4@% 
to 50% after one to four bolur injections of 0.45 mglkg of 
11.PA. 
Pathologic examination (Table 4). The extent of arterial 
thrombosis was graded as occlusive thrombus. panial!y 
~CCIU~I~E Lhrombus. mural rhrombus and patent artery. and 
the composioon of the thrombus as plate!et-rich, crythm- 
cyte-nch or mixed with interlaced platel+ch and erythro- 
cyfe-rich Ihrombus. Among nine dogs in groups 1 to 111. the 
persisfrntly occlusive rhrombus car&e? of transluminal 
platelet-rich rhrombus in five. mixed thrombtrs in three and 
primarily eryrhmcyte-rich clot in one. Among six dogs in 
groups Ill and IV, rep&used arteries were devoid of rhrom- 
boric material in three and contained residual mural mined 
lhrombus I” the other three. Typical examples of everted 
segrnent~ are represented in Figure 3. 
Thrornbolytic lhcrapy ofacute myocardial infarction with 
rccombmam tissue-rvpe plasminopn activator (n-PA) holds 
promise for the reduction of morbidiry and monalily in 
1732 
patients with acute myocardial infarction. However, the 
success of coronary thrombolysis, which is a primary dctcr- 
minant of clinical outcome. appears to be limited to approx- 
imately 70% of patients. This resistance to repcrfusion may 
be due to lumin~l compression by intraplaque hemorrhage & 
coronary artery dissection or tu intrinsic resistance of the 
thrombus to lysis. 
Table 4. Resull~ of Pathologic Analysis of Evened Coronary 
Arterv Seernerds 
Platelet+kh thmmhus and sensltlvity to Lmmbolysb. 
One oflhe mechanisms by which thrombus may be resistant 
to lysis may be the relative content of piatc!etr. Indeed, 
piatclet aggregates in vitro can only be dispersed with very 
high concentrations of r&PA (16). whereas in a rabbit model 
of femoral artery thrombosis (9). erythrocyte-rich clots are 
much more sensitive to Ivsis with r&PA lhan is olatelet-rich 
thrombus. In addition, ;he triggering event if coronary 
thrombosis at the site of plaque rupture appears to be a 
olatelet-mediated ohenomenon 001. This mav exolain whv 
&te reocclusion bfcnronery arteries efter suCces& I-Q& 
fusion is not adequately prevented by heparin anticaagula- 
lion. as was demonstrated in 5 of 25 patients during contin- 
uous an&graphic monitoring (17). 
Animal models for coronary thrombolysis have primwily 
been based on whole blood clots in isolated segments of Ihe 
coronary artery (18) or on thrombus induced with copper 
coils (19). Because relative resistance of platelet-rich thrc ,a~- 
bus lo Iysis with r&PA has been demonstra!ed in a rat bit 
model o$ femoral artery thrombosis (9). we developed he 
present canine model of platelet-rich coronary artery throm- 
bosis. Thrombus models consisting primarily of p!stelet-r ch 
do !wc also previously been described. The original mwlel 
~??olts et al. (201, consisting of a stenoned coronruy artery 
with an external luminal constriction to 70%, is subject to 
spontaneous cyclic occlusion with platelet-rich material. 
although such occlusion cau be prevented by administration 
of aspirin. More extensive conuricrion (~-90%) requires 
more intensive therapy with antiplatelet agents to prevent 
cyclic occlusian, but this modification also does not produce 
stable coronary artery occlusion (21.22). Alternatively, mod- 
els of platelet-rich thmmhus based on intraluminal electrical 
>timJ!Pion have been used 123.24) and in rhesc mod&. 
Qotcnriation of thrombolysis with antiQk+lelet antibodies !a 
been derronxtrated (24j. However, th&e models lack a high 
gradr stenosi\. which makrs coronary thrombl much more 
r&tant 10 lyais (II). 
Our prrrrn, IINJCI is chuructrrized bg mx bu~ns~ brrrl 
lrirwrrnp mrrhmtbm fur plurrlur-mudiurrd ocrbtsion. re- 
sullmg pnmarily in a persislenl platelet-rich or mixed plate. 
let-nch and erythrocyte-rich occlusive tbrombuc. This 
thrombus develops within approximately 5 min in Sff/, o! the 
Boil& and extends over a 1 cm segment. In addition. a 
wQUimQu\ed exte~al constriction reduces the lumeul di- 
ilmeler by at least 9oc/o and decreases the blwd Row to 40% 
of biwlme (II). We anticipated that this model might be 
uscfol for mvesligarmg specific pharmacologic strategies to 
disperse platelet-rich coronary thrombo, formed in a 
stenosed coronary artery. 
Chnrocteristics of the canine waled circumflex artery 
~egtttent m&i. This model is stable and reproducible. In 
experiments m 27 dogs. spontnneoos stable occlusive throm- 
busis INink! for at least 30 min was obtained in 20 dogs. In 
five dogs. cyclic episodes of reperfusion and reocclusion 
occurred. whetas in IWO dogs, the surgical procedure 
failed. In a control group of 5 of these 20 dogs with persis:ent 
occlusion for 30 min. the circumflex coronary artery occlu- 
sion persisted throu&hout the 2 h ahsenation period. Re- 
peated bolus injeclions of 0.45 mgikg of n-PA, which are 
known to consistently CBUS’I ret7ow in coronary arteries 
occluded with whole blood clots (20). did not produce reflow 
in four of five dogs and caused cyclic reperfousion and 
reocclusion in the fifth dog. Bolus injections of 0.8 mglkg OF 
7E3-F(ab’12. which saturated X0% to 90% of the platelet 
GPllbillla receptors. caused rep&&t without subse- 
quent reocclusion in two f five dogs. whereas the coxbina- 
lion of 7E3-F(ab’)Z and n-PA caused reperfusion without 
reocclus~on in ~111 five dogs tested. 
From thvrr observations. WC can drrrw srveral concbr- 
siow. I) platelet-rich thrombus is indeed resistant to disper- 
sion wnh MA; 2) a potent antiplatelet agent such as 
7E3-F(ab’)Z does not cbnsistently bisperse the osclusi\re 
platelet-rich thrombus: and 3) the use of 7E3-Nab’12 note”. 
iiates reperfusian. even with a educed dose of rl.PAl 
Combined r&PA and anlidatelet aeent Imowelonal anti- ” . 
body). We (25.261 have prev~oosly shown that the combina- 
Lion of 7E3-FM’)2 and n-PA accelerates lvsis of a whole 
blood clot and prevents reocclosion by platelet-rich material 
m a canmc model of coronary artery thrombosis. Further- 
more. m a mbblt model of femoral artery eversion. the 
rclal~vc resistance of platelet-rich thrombus was previously 
estabhshrd 19). Our working hypothesis that the combinw 
tion of rr-PA and 7E3-F(db’)? might overcome the resistance 
of primary plateiet-rich lhrombus to lysis was confirmed in 
the presem study. Because of the species specificity af the 
monoclonal zealbody. this combination could not be studied 
in the rabbit. Furthermore. inview offulure invesiigationsof 
alternative reperfusion strategies for platelet-rich coronary 
thromhus. we purposely selected the canine species, which 
permits closer simulation of the anatomic features of core- 
oarv thrombosis in acute mvocardial infarction. 
claw. If ;-PA disper& th; thmmhus by dissolution of the 
fibrin strands that hold the platelet clumps together. one 
would not expect such great resislance to thrombolysis with 
r&PA alone at doses that efficiently dissolve erythrocyte-rich 
clot (25,26). Possibly, inhibition of the accretion of new 
platelets on the thrombus surface may shift the dynamic 
balance of thrombosis and thromholysis toward the latter. 
Potential clinical relevance. There is a marked interactive 
effect of thrombolytic agents and agents that inhibit platelet 
aggregation, both in relation to lysis of platelet-rich throm- 
bus. as in the present study, and in preventing reocclusion, 
as in the oresent and previous studies (25.26). This interac- 
tion mey &lain the abditive effects of aspirin and streptoki- 
nase on mortality reduction observed in the Second Interna- 
tional Study of Infarct Survival (ISIS-2) (3). Still, the 
enhancing effect of aspirin and n-PA does not appear to 
consistently overcotne the initial resistance of platelet-rich 
thrombus to lysis, as evidenced by the submaximal reperfu- 
sion frequencies observed with the combination of aspirin 
and r&PA in the rabbit femoral anew eversion craft model 
Uang et al., unpublished observation& The ma&d proton- 
gation of the bleeding time at the high dose of 7E?-Nab’12 
used in the present study will requirefurther dose-response 
studies before potential use of this agent can he studied in 
human patients. In addition. further investigation of alterna- 
tive reversible antiplatelet agents in combination with rt-PA 
is warranted, with respect o their effect on both platelet-tich 
coronary thrombus and bleeding. 
lo view of thr !wwn vari:able morphology of coronary 
thmmbi in patients with acute myocar&l in&ion. recent 
evidence that the combination of antidalelet and throm- 
holytic agents improves clinical outco& and the results of 
the present experimental study, optimization of combined 
antiplatelet and thrombolytic strategies may constitute a 
successful approach for funhcr improvement of throm- 
holytic therapy in patients with itcute coronary syndromes. 

